ProShares Trust II (UVXY) - Dilution Analysis

10-Q filing | 295.0M shares outstanding

10-Q filing | 147.2M shares outstanding

10-Q filing | 110.5M shares outstanding

S-3/A filing: This SEC filing relates to legal proceedings involving GS&Co. as an underwriter in several securities offerings, focusing on allegations of material misstatements and omissions in offering documents.

S-3/A filing: This is an S-3/A filing on 2025-03-18, discussing underwriting litigation related to securities offerings from SunEdison, Valeant Pharmaceuticals, Snap Inc., and Altice USA, Inc., with allegations of material misstatements and omissions in offering documents.

S-1/A filing: This is an S-1/A filing on 2025-03-18. It discusses underwriting litigation related to securities offerings, including those of SunEdison, Valeant Pharmaceuticals, Snap Inc., and Altice USA, Inc.

10-K filing | 132.4M shares outstanding

S-1 filing: This SEC filing discusses underwriting litigation related to securities offerings by GS&Co., including cases involving SunEdison, Valeant Pharmaceuticals, Snap Inc., and Altice USA.

S-3 filing: The filing discusses legal proceedings against GS&Co. related to alleged misstatements and omissions in offering documents for various securities offerings, including SunEdison, Valeant Pharmaceuticals, Snap Inc., and Altice USA, Inc.

S-3 filing: This SEC filing discusses underwriting litigation involving GS&Co. in connection with securities offerings, including SunEdison, Valeant Pharmaceuticals, Snap Inc., and Altice USA, Inc.

10-Q filing | 173.8M shares outstanding

10-Q filing | 147.1M shares outstanding

10-Q filing | 126.2M shares outstanding

POS AM filing: This document discusses underwriting litigation involving GS&Co. in connection with securities offerings, including SunEdison, Valeant Pharmaceuticals, Snap Inc., and Altice USA, Inc.

10-K filing | 145.1M shares outstanding

10-Q filing | 106.3M shares outstanding

10-Q filing | 108.6M shares outstanding

10-Q filing | 631.5M shares outstanding

POS AM filing: This is a POS AM filing mentioning several securities class actions related to public offerings underwritten by GS&Co.

POS AM filing: This document discusses underwriting litigation involving Goldman Sachs as underwriter in multiple securities offerings, including ViacomCBS, SunEdison, Valeant Pharmaceuticals, and Snap Inc.

POS AM filing: This is a POS AM filing from 2023-03-27 discussing legal proceedings against GS&Co. in connection with various securities offerings.

10-K filing | 461.9M shares outstanding

POS AM filing: This is a POS AM filing that discusses various legal proceedings involving Goldman Sachs, including antitrust claims, securities class actions, and underwriting litigation related to ViacomCBS and SunEdison.

POS AM filing: This is a POS AM filing that discusses legal proceedings related to Currencies-Related Litigation, Archegos-Related Matter, Underwriting Litigation, and SunEdison, Inc.

10-Q filing | 183.9M shares outstanding

POS AM filing: This is a POS AM filing that discusses several legal proceedings in which Goldman Sachs is involved, including antitrust claims, securities class actions related to ViacomCBS and SunEdison, and other underwriting litigation.

POS AM filing: This is a POS AM filing that discusses various legal proceedings in which GS&Co. is involved, including class action lawsuits related to securities offerings and antitrust claims.

10-Q filing | 260.8M shares outstanding

POS AM filing: This is a POS AM filing that discusses underwriting litigation related to securities offerings by GS&Co.

POS AM filing: This document discusses underwriting litigation involving GS&Co. as a defendant in securities class actions related to public offerings of various companies, including ViacomCBS, SunEdison, Valeant Pharmaceuticals, and Snap Inc.

10-Q filing | 222.5M shares outstanding

10-K filing | 145.9M shares outstanding

S-3/A filing: The filing discusses litigation involving Goldman Sachs and GS&Co. related to several securities offerings, including SunEdison, Valeant Pharmaceuticals, Snap Inc., and Altice USA, Inc. The plaintiffs allege material misstatements and omissions in the offering documents.

S-3/A filing: This is an S-3/A filing made on 2022-02-15. The filing discusses underwriting litigation, specifically proceedings related to securities offerings where GS&Co. is named as a defendant.

S-1 filing: This SEC filing discusses underwriting litigation involving GS&Co. in connection with securities offerings of SunEdison, Valeant Pharmaceuticals, Snap Inc., and Altice USA, Inc.

S-3 filing: This SEC filing discusses legal proceedings involving Goldman Sachs and other defendants related to alleged misstatements and omissions in offering documents for securities offerings of SunEdison, Valeant Pharmaceuticals, Snap Inc., and Altice USA, Inc.

S-1/A filing: This document discusses underwriting litigation involving GS&Co. in connection with securities offerings, including SunEdison, Valeant Pharmaceuticals, Snap Inc., and Altice USA, Inc.

S-3 filing: This filing discusses legal proceedings involving Goldman Sachs related to securities offerings, including SunEdison, Valeant Pharmaceuticals International, and Snap Inc.

10-Q filing | 165.1M shares outstanding

S-3 filing: The filing discusses legal proceedings involving Goldman Sachs and GS&Co. as underwriters and initial purchasers in securities offerings of SunEdison, Valeant Pharmaceuticals, and Snap Inc., alleging material misstatements and omissions in offering documents and seeking damages.

S-1 filing: The filing discusses legal proceedings involving Goldman Sachs and its subsidiaries related to securities offerings and other matters.

10-Q filing | 102.7M shares outstanding

10-Q filing | 344.9M shares outstanding

S-1/A filing: The filing discusses legal proceedings involving Goldman Sachs, including matters related to currency exchange manipulation, underwriting of securities offerings for SunEdison and Valeant Pharmaceuticals.

S-3/A filing: This is an S-3/A filing providing information on legal proceedings involving Goldman Sachs & Co. LLC, including litigation related to securities offerings such as the SunEdison, Inc. convertible preferred stock offering.

10-K filing | 130.4M shares outstanding

S-3 filing: This SEC filing discusses legal proceedings involving Goldman Sachs and its subsidiaries, including litigation related to currencies, underwriting activities (specifically SunEdison, Valeant Pharmaceuticals, and Snap Inc. offerings).

10-Q filing | 180.2M shares outstanding

S-1 filing: This is an S-1 filing, but it primarily discusses futures contracts, forward contracts, margin requirements, and FCM agreements related to trading activities. There is no specific offering of securities described within the provided text.

10-Q filing | 153.4M shares outstanding

10-Q filing | 0.1M shares outstanding

S-1/A filing: The filing describes the plan of distribution for shares of the fund, including the role of authorized participants and the potential for statutory underwriters.

S-1/A filing: The filing discusses the plan of distribution for shares of the Funds, including buying and selling shares through brokers, offerings to Authorized Participants, and the likelihood of becoming a statutory underwriter.

S-1 filing: The filing is an S-1 for a fund that continuously offers shares in Creation Units to Authorized Participants. Authorized Participants may then offer these shares to the public at market price.

10-K filing | 130.4M shares outstanding